Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotic Intervention in Ovarian Cancer Patients Undergoing Platinum Chemotherapy
NCT07144826Phase 1Recruiting
- Sponsor
- The Ohio State University Comprehensive Cancer Center – James Cancer Hospital
- Start
- Mar 2026
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in ovarian cancer (2 arms), sponsored by The Ohio State University Comprehensive Cancer Center – James Cancer Hospital. Primary endpoint: Changes to the gut microbiome composition at cycle 6. Started Mar 2026; status: recruiting.
02
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT07144826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07144826.